Lenalidomide Grindeks (Lenalidomide)

The drug binds to cereblon, a component of the CRL4‑E3 ubiquitin ligase complex, changing its substrate profile. This leads to the targeted degradation of transcription factors Ikaros and Aiolos, which disrupts malignant cell survival, reduces pro‑inflammatory cytokines, inhibits new blood‑vessel formation, and enhances immune‑mediated tumor cell killing.

The specific dose of Lenalidomide Grindeks is determined by the prescribing physician based on the patient’s diagnosis, disease stage, renal function, and prior therapies. Dosage regimens are individualized and should follow the latest clinical guidelines and the prescriber’s clinical judgment.

Lenalidomide is classified as Pregnancy Category X because it is known to cause severe fetal malformations and embryotoxicity. It is contraindicated in pregnancy, and effective contraception must be used during treatment and for at least four weeks after the last dose. Breastfeeding is not recommended while taking the drug.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Lenalidomide Grindeks. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Lenalidomide is a second‑generation immunomodulatory drug that offers greater potency and a more favorable safety profile than thalidomide, the first‑generation analogue. Compared with pomalidomide, another IMiD, lenalidomide is generally used earlier in therapy and has a broader label for multiple myeloma and certain myelodysplastic syndromes.

Store Lenalidomide Grindeks at temperatures below 25 °C, in its original container, and protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid crushing or splitting tablets unless specifically instructed by a pharmacist.

Lenalidomide Grindeks is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a full glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider and not alter the timing without medical advice.

The most critical risks include teratogenicity, which can cause birth defects; venous thromboembolism, especially when combined with other agents; severe neutropenia or thrombocytopenia that can lead to infection or bleeding; and the possible development of secondary primary malignancies. Prompt reporting of any unusual symptoms to a healthcare professional is essential.

Lenalidomide Grindeks should not be used by pregnant women or women who could become pregnant without reliable contraception. Patients with severe renal impairment who cannot be dose‑adjusted, those with uncontrolled infections, and individuals taking contraindicated medications such as live vaccines should avoid the drug unless a specialist determines it is safe.